• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于细胞的剪接报告系统,用于鉴定相邻基因之间顺式剪接的调控因子。

A cell-based splicing reporter system to identify regulators of cis-splicing between adjacent genes.

机构信息

Department of Pathology, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.

Department of Biochemistry and Molecular Genetics, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.

出版信息

Nucleic Acids Res. 2019 Feb 28;47(4):e24. doi: 10.1093/nar/gky1288.

DOI:10.1093/nar/gky1288
PMID:30590765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6393300/
Abstract

Chimeric RNAs generated by cis-splicing between adjacent genes (cis-SAGe) are increasingly recognized as a widespread phenomenon. These chimeric messenger RNAs are present in normal human cells, and are also detected in various cancers. The mechanisms for how this group of chimeras is formed are not yet clear, in part due to the lack of a tractable system for their experimental investigation. Here we developed a fast, easy and versatile cell-based reporter system to identify regulators of cis-SAGe. The reporter, consisting of four main cassettes, simultaneously measures the effects of a candidate regulator on cis-SAGe and canonical splicing. Using this cell-based assay, we screened 102 candidate factors involved in RNA pol II cleavage and termination, elongation, splicing, alternative splicing and R-loop formation. We discovered that two factors, SRRM1 and SF3B1, affect not only cis-SAGe chimeras, but also other types of chimeric RNAs in a genome-wide fashion. This system can be used for studying trans-acting factors and cis-acting sequence elements and factors, as well as for screening small molecule inhibitors.

摘要

由相邻基因(顺式剪接)之间的顺式拼接产生的嵌合 RNA(cis-SAGe)越来越被认为是一种广泛存在的现象。这些嵌合信使 RNA 存在于正常的人类细胞中,也在各种癌症中被检测到。由于缺乏可用于其实验研究的可行系统,目前尚不清楚这组嵌合体形成的机制。在这里,我们开发了一种快速、简单且通用的基于细胞的报告系统,以鉴定 cis-SAGe 的调节因子。该报告系统由四个主要盒组成,可同时测量候选调节剂对 cis-SAGe 和规范剪接的影响。使用这种基于细胞的测定法,我们筛选了 102 种候选因子,这些因子涉及 RNA pol II 切割和终止、延伸、剪接、选择性剪接和 R 环形成。我们发现,两个因子,SRRM1 和 SF3B1,不仅影响 cis-SAGe 嵌合体,而且还以全基因组的方式影响其他类型的嵌合 RNA。该系统可用于研究反式作用因子和顺式作用序列元件和因子,以及筛选小分子抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/0ffadf815909/gky1288fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/02acb9b0a8a4/gky1288fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/2d18cdc603b1/gky1288fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/71fbeebde2f7/gky1288fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/0ffadf815909/gky1288fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/02acb9b0a8a4/gky1288fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/2d18cdc603b1/gky1288fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/71fbeebde2f7/gky1288fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4e/6393300/0ffadf815909/gky1288fig4.jpg

相似文献

1
A cell-based splicing reporter system to identify regulators of cis-splicing between adjacent genes.一种基于细胞的剪接报告系统,用于鉴定相邻基因之间顺式剪接的调控因子。
Nucleic Acids Res. 2019 Feb 28;47(4):e24. doi: 10.1093/nar/gky1288.
2
Discovery of CTCF-sensitive Cis-spliced fusion RNAs between adjacent genes in human prostate cells.人类前列腺细胞中相邻基因间CTCF敏感的顺式剪接融合RNA的发现。
PLoS Genet. 2015 Feb 6;11(2):e1005001. doi: 10.1371/journal.pgen.1005001. eCollection 2015 Feb.
3
Generation of Chimeric RNAs by cis-splicing of adjacent genes (cis-SAGe) in mammals.哺乳动物中通过相邻基因的顺式剪接(cis-SAGe)产生嵌合RNA
Yi Chuan. 2018 Feb 20;40(2):145-154. doi: 10.16288/j.yczz.17-197.
4
A Genetic Screen for Pre-mRNA Splicing Mutants of Identifies Putative U1 snRNP Components RBM25 and PRP39a.一种鉴定 U1 snRNP 假定成分 RBM25 和 PRP39a 的前体 mRNA 剪接突变体的遗传筛选。
Genetics. 2017 Dec;207(4):1347-1359. doi: 10.1534/genetics.117.300149. Epub 2017 Sep 29.
5
Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.与癌症相关的SF3B1突变体可识别RNA二级结构中原本无法接近的隐蔽3'剪接位点。
Oncogene. 2017 Feb 23;36(8):1123-1133. doi: 10.1038/onc.2016.279. Epub 2016 Aug 15.
6
Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.鉴定癌症相关 SF3B1 突变诱导的 MAP3K7 剪接异常。
J Biochem. 2021 Sep 22;170(1):69-77. doi: 10.1093/jb/mvab023.
7
Mutational landscape of RNA-binding proteins in human cancers.RNA 结合蛋白在人类癌症中的突变全景。
RNA Biol. 2018 Jan 2;15(1):115-129. doi: 10.1080/15476286.2017.1391436. Epub 2017 Nov 14.
8
Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.剪接因子 SF3B1 通过调节 KSR2 RNA 的成熟促进子宫内膜癌的进展。
Cell Death Dis. 2020 Oct 10;11(10):842. doi: 10.1038/s41419-020-03055-y.
9
A high-throughput screen identifies small molecule modulators of alternative splicing by targeting RNA G-quadruplexes.高通量筛选通过靶向 RNA G-四联体识别剪接的小分子调节剂。
Nucleic Acids Res. 2019 Apr 23;47(7):3667-3679. doi: 10.1093/nar/gkz036.
10
Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins.剪接事件在基因组完整性控制中的作用:SLU7 和截断 SRSF3 蛋白的作用。
Nucleic Acids Res. 2019 Apr 23;47(7):3450-3466. doi: 10.1093/nar/gkz014.

引用本文的文献

1
Revealing the role of U2AF1 in splicing regulation and chimeric RNA dynamics.揭示U2AF1在剪接调控和嵌合RNA动态变化中的作用。
Sci Rep. 2025 May 9;15(1):16235. doi: 10.1038/s41598-025-99865-1.
2
Oncogenic fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability.致癌融合蛋白与多嘧啶序列结合蛋白1相互作用,通过调节mRNA稳定性促进膀胱癌的增殖和转移。
MedComm (2020). 2024 Aug 14;5(9):e685. doi: 10.1002/mco2.685. eCollection 2024 Sep.
3
Network Analysis of Osteoarthritis Progression Using a Steiner Minimal Tree Algorithm.

本文引用的文献

1
Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.抑制剪接体的 SF3B1 可导致大量异常外显子跳过。
RNA. 2018 Aug;24(8):1056-1066. doi: 10.1261/rna.065383.117. Epub 2018 May 29.
2
Connections between Transcription Downstream of Genes and cis-SAGe Chimeric RNA.基因下游转录与顺式SAGe嵌合RNA之间的联系。
Genes (Basel). 2017 Nov 22;8(11):338. doi: 10.3390/genes8110338.
3
Chimeric RNAs and their implications in cancer.嵌合 RNA 及其在癌症中的意义。
使用斯坦纳最小树算法对骨关节炎进展进行网络分析
J Inflamm Res. 2024 May 18;17:3201-3209. doi: 10.2147/JIR.S438407. eCollection 2024.
4
Chimeric RNAs and their implication in prostate cancer.嵌合RNA及其在前列腺癌中的意义。
Cancer Pathog Ther. 2023 May 1;1(3):216-219. doi: 10.1016/j.cpt.2023.04.003. eCollection 2023 Jul.
5
CTNNBIP1-CLSTN1 functions as a housekeeping chimeric RNA and regulates cell proliferation through SERPINE2.CTNNBIP1-CLSTN1作为一种管家嵌合RNA发挥作用,并通过SERPINE2调节细胞增殖。
Cell Death Discov. 2023 Oct 7;9(1):369. doi: 10.1038/s41420-023-01668-8.
6
CTNNBIP1-CLSTN1 Functions as a Housekeeping Chimeric RNA, and Regulates Cell Proliferation through SERPINE2.CTNNBIP1-CLSTN1作为一种管家嵌合RNA发挥作用,并通过SERPINE2调节细胞增殖。
Res Sq. 2023 Jul 17:rs.3.rs-3112431. doi: 10.21203/rs.3.rs-3112431/v1.
7
Chimeric RNA plays an oncogenic role in the development of NNK-induced lung cancer.嵌合RNA在NNK诱导的肺癌发生发展中发挥致癌作用。
iScience. 2022 Dec 2;26(1):105708. doi: 10.1016/j.isci.2022.105708. eCollection 2023 Jan 20.
8
Chimeric RNAs Discovered by RNA Sequencing and Their Roles in Cancer and Rare Genetic Diseases.通过 RNA 测序发现的嵌合 RNA 及其在癌症和罕见遗传疾病中的作用。
Genes (Basel). 2022 Apr 22;13(5):741. doi: 10.3390/genes13050741.
9
Identification of the cross-strand chimeric RNAs generated by fusions of bi-directional transcripts.双向转录本融合产生的链间嵌合 RNA 的鉴定。
Nat Commun. 2021 Jul 30;12(1):4645. doi: 10.1038/s41467-021-24910-2.
10
Tear Film Proteome of Healthy Domestic Cats.健康家猫的泪膜蛋白质组
Vet Med Int. 2021 Jul 15;2021:8708023. doi: 10.1155/2021/8708023. eCollection 2021.
Curr Opin Genet Dev. 2018 Feb;48:36-43. doi: 10.1016/j.gde.2017.10.002. Epub 2017 Nov 5.
4
Chimeric RNAs in cancer and normal physiology.癌症与正常生理状态下的嵌合RNA
Wiley Interdiscip Rev RNA. 2017 Nov;8(6). doi: 10.1002/wrna.1427. Epub 2017 Jun 7.
5
Recurrent fusion RNA DUS4L-BCAP29 in non-cancer human tissues and cells.非癌性人体组织和细胞中存在复发性融合RNA DUS4L-BCAP29 。
Oncotarget. 2017 May 9;8(19):31415-31423. doi: 10.18632/oncotarget.16329.
6
Intergenically Spliced Chimeric RNAs in Cancer.癌症中的基因间剪接嵌合RNA
Trends Cancer. 2016 Sep;2(9):475-484. doi: 10.1016/j.trecan.2016.07.006.
7
Modeling SF3B1 Mutations in Cancer: Advances, Challenges, and Opportunities.癌症中SF3B1突变的建模:进展、挑战与机遇
Cancer Cell. 2016 Sep 12;30(3):371-373. doi: 10.1016/j.ccell.2016.08.013.
8
Recent advances in understanding transcription termination by RNA polymerase II.RNA聚合酶II转录终止机制研究的最新进展
F1000Res. 2016 Jun 23;5. doi: 10.12688/f1000research.8455.1. eCollection 2016.
9
Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer.前列腺癌中复发性顺式SAGe嵌合RNA,D2HGDH-GAL3ST2
Cancer Lett. 2016 Sep 28;380(1):39-46. doi: 10.1016/j.canlet.2016.06.013. Epub 2016 Jun 17.
10
Transcriptional termination in mammals: Stopping the RNA polymerase II juggernaut.哺乳动物中的转录终止:让RNA聚合酶II停下脚步
Science. 2016 Jun 10;352(6291):aad9926. doi: 10.1126/science.aad9926.